21.850
+4,05%
2026-10-19
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -94.6% | -113.5% | 0 / 3 | -21.4% | -8.62 pp | -11.66 pp | +0.3% | 0.20 | 314.91 | 69,6 | −21,4% | 0,6 | −94,6% | 314.91 | 9.59 | +3.183,7% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 21.850 (close price on 2026-10-19)EPS (TTM): 69,4
Financial charts
1.Revenue & growth
VND bn69,6Q2/26
1.Revenue & growth
VND bn69,6Q2/26
2.Profit & growth
VND bn0,48Q2/26
3.Profit mix (Penman)
VND bn4,85Q2/26
4.Margins & cost structure
%26.9%Q2/26
5.Returns & cash cycle
% · days0.3%Q2/26
6.Earnings quality & cash
VND bn33,4Q2/26
7.Asset structure
VND bn546Q2/26
8.Funding & debt health
VND bn · times546Q2/26
9.Revenue backlog
VND bn8,06Q2/26
10.Valuation
times · %362,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %32Q2/26
Adjusted EPS growth, latest quarter
-95.7%
Average adjusted EPS growth, 3 quarters
-114%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26